I am a
Home I AM A Search Login

Papers of the Week

2021 Mar 12

J Eur Acad Dermatol Venereol

Nemolizumab is Associated with a Rapid Improvement in Atopic Dermatitis Signs and Symptoms: Subpopulation (EASI ≥16) Analysis of Randomized Phase 2B Study.


Silverberg JI, Pinter A, Alavi A, Lynde C, Bouaziz J-D, Wollenberg A, Murrell DF, Alpizar S, Laquer V, Chaouche K, Ahmad F, Armstrong JM, Piketty C
J Eur Acad Dermatol Venereol. 2021 Mar 12.
PMID: 33711179.


Nemolizumab is a humanized anti-IL-31 receptor blocker in phase 3 for atopic dermatitis (AD).